Displaying 3341 - 3360 of 4794
Statement of the Federal Trade Commission Concerning the Proposed Acquisition of Medco Health Solutions by Express Scripts, Inc.
FTC Closes Eight-Month Investigation of Express Scripts, Inc.'s Proposed Acquisition of Pharmacy Benefits Manager Medco Health Solutions, Inc.
FTC Chairman Releases 2011-2012 Annual Highlights
FTC Testifies on Proposed Antitrust Exemption for Community Pharmacies
Citing Likely Anticompetitive Effects, FTC Requires ProMedica Health System to Divest St. Luke's Hospital in Toledo, Ohio, Area
FTC Orders Graco Inc. to Hold Separate Worldwide Liquid Finishing Equipment Businesses it is Acquiring from its Rival, ITW
1203011 Informal Interpretation
FTC Seeks U.S. Supreme Court Review of Appeals Court Rulingin Phoebe Putney/Palmyra Park Hospital Case
Second Firm Agrees to Settle FTC Charges of Collusion in the Market for Pipe Fittings Used by Municipal Water Systems
FTC Approves Dow Chemical's Application to Sell Torrance, California, Chemicals Facility to Hager Pacific Acquisitions LLC
Dow Chemical Company, The
The Commission challenged Dow Chemical’s $18.8 billion proposed acquisition of Rohm & Haas Company as anticompetitive in the markets for various acrylics and other industrial chemicals used to make coated paper products, paints, and adhesives. According to the Commission’s complaint, the product markets in question include acrylic monomers, used in goods ranging from hygiene products to paints and industrial coatings, hollow sphere particles, used in paper products, and acrylic latex polymers, used in traffic paints. Given the high concentration in each of the product markets, the proposed acquisition would have represented a merger to monopoly. To remedy its anticompetitive concerns, the Commission required Dow to divest assets to Hager Pacific Acquisitions LLC.
Healthcare Technology Holdings, Inc., In the Matter of
The FTC reached a settlement with Healthcare Technology Holdings, Inc., the parent company of market research firm IMS Health Inc., according to which IMS has agreed to sell two product lines of rival SDI Health LLC, as a condition of allowing it to proceed with its acquisition of SDI. The proposed settlement order requires the sale of SDI's promotional audit and medical audit businesses to an FTC-approved buyer to resolve the agency's charges that IMS's acquisition of SDI, as originally proposed, is anticompetitive and likely would increase prices for market research products in the health care industry. On1/10/2012, the FTC approved a modified final order settling the charges.
FTC Approves Healthcare Technology's Application to Sell SDI Health's Audit Businessess
FTC Action Preserves Competition in the Market for Desktop Hard Disk DrivesUsed in Personal Computers
FTC Puts Conditions on Carpenter Technology Corporation's Purchase of Rival Manufacturer Latrobe Specialty Metals, Inc.
FTC Requires Fresenius Medical Care AG to Sell 60 Dialysis Clinics Around the Country as a Condition of Acquiring Liberty Dialysis Holdings, Inc.
FTC Approves Final Order Settling Charges that Sigma Corporation Acted Anticompetitively in Market for Municipal Water System Iron Pipe FittingsFTC Determines Not to Modify Final Order Settling Charges that AmeriGas's Proposed Acquisition of Rival
Sigma Corporation, In the Matter of
The FTC filed separate complaints against the three largest U.S. suppliers of ductile iron pipe fittings, which are used in municipal water systems around the United States. The FTC charged that the three companies, McWane, Inc., Star Pipe Products, Ltd., and Sigma Corporation, illegally conspired to set and maintain prices for pipe fittings, and that McWane illegally maintained its monopoly power in the market for U.S.-made pipe fittings by implementing an exclusive dealing policy. Sigma settled the FTC's charges prior to litigation (final order dated Feb. 27, 2012); Star settled soon after (final order dated May 8, 2012). The complaint against McWane was heard before an administrative law judge and later appealed to the Commission; see Docket No. 9351.
FTC Seeks Public Comment on Cardinal Health, Inc.'s Application to Sell Nuclear Pharmacy Assets to Patient Care Infusion, LLC
Displaying 3341 - 3360 of 4794